Ndongo, Aliou Abdoulaye and Boiro, Djibril and Basse, Idrissa and Kéita, Younoussa and Seck, Ndiogou and Thiam, Lamine and Van Immerzeel, Tabitha D. and Sylla, Assane (2021) Factors Affecting the Statural Growth Retardation in Children using Steroids in Idiopathic Nephrotic Syndrome. Asian Journal of Pediatric Research, 7 (4). pp. 70-76. ISSN 2582-2950
131-Article Text-217-1-10-20220919.pdf - Published Version
Download (457kB)
Abstract
Background and Aim: Idiopathic nephrotic syndrome or nephrosis causes massive protein leakage in the urine. Its treatment requires steroids (prednisone, methylprednisolone), often for a prolonged period, notably in case of steroid-dependence or steroid-resistance. In children, long-term use of steroids can lead to several side effects such as statural growth retardation/ stunting. This study evaluated the frequency of stunting in idiopathic nephrotic syndrome in children on steroids and identified the associated factors.
Material and Methods: This was a retrospective, descriptive cohort study carried out in children aged 0 to 16 years treated at the paediatric nephrology unit of Aristide Le Dantec Hospital in Dakar, between 1 December 2017 and 31 May 2020. All records of nephrotic children treated in outpatient or inpatient setting were included. These children had to be on corticosteroid therapy for at least 30 months and have a height taken regularly during follow-up consultations.
Results: Of 259 children followed for idiopathic nephrotic syndrome, 93 were included in the study. The median age was 96.5 months and the sex ratio was 1.9. The mean height of the children at the beginning of the follow-up was -0.26 DS, at the end it was -0.88 DS. At the beginning of the follow-up, 8 children had already stunting. At 12 months follow-up, 72 children (77.4%) had a decrease in z-score; and at 30 months, there were 7 more children (84.9%) who had a decrease in z-score. Methylprednisolone boluses were given to 17 children (18.3%). Calcium supplementation was done in 91 children (97.8%). Vitamin D supplementation was given to 91 children (97.8%). The mean number of relapses was 1.8. Factors associated with stunting were number of relapses ≤3 (p=0.03), duration of corticosteroid therapy >6 months (p<0.0001) and cumulative doses of prednisone >100 mg/kg (p=0.04).
Conclusion: In prolonged nephrotic syndrome in children, corticosteroids can cause stunting.
Item Type: | Article |
---|---|
Subjects: | Article Archives > Medical Science |
Depositing User: | Unnamed user with email support@articlearchives.org |
Date Deposited: | 31 Jan 2023 07:27 |
Last Modified: | 05 Jul 2024 08:49 |
URI: | http://archive.paparesearch.co.in/id/eprint/317 |